Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive c...
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial
About this item
Full title
Author / Creator
Sharman, Jeff P , Egyed, Miklos , Jurczak, Wojciech , Skarbnik, Alan , Pagel, John M , Flinn, Ian W , Kamdar, Manali , Munir, Talha , Walewska, Renata , Corbett, Gillian , Fogliatto, Laura Maria , Herishanu, Yair , Banerji, Versha , Coutre, Steven , Follows, George , Walker, Patricia , Karlsson, Karin , Ghia, Paolo , Janssens, Ann , Cymbalista, Florence , Woyach, Jennifer A , Salles, Gilles , Wierda, William G , Izumi, Raquel , Munugalavadla, Veerendra , Patel, Priti , Wang, Min Hui , Wong, Sofia and Byrd, John C
Publisher
England
Journal title
Language
English
Formats
Publication information
Publisher
England
Subjects
More information
Scope and Contents
Contents
Acalabrutinib is a selective, covalent Bruton tyrosine-kinase inhibitor with activity in chronic lymphocytic leukaemia. We compare the efficacy of acalabrutinib with or without obinutuzumab against chlorambucil with obinutuzumab in patients with treatment-naive chronic lymphocytic leukaemia.
ELEVATE TN is a global, phase 3, multicentre, open-lab...
Alternative Titles
Full title
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Egyed, Miklos
Jurczak, Wojciech
Skarbnik, Alan
Pagel, John M
Flinn, Ian W
Kamdar, Manali
Munir, Talha
Walewska, Renata
Corbett, Gillian
Fogliatto, Laura Maria
Herishanu, Yair
Banerji, Versha
Coutre, Steven
Follows, George
Walker, Patricia
Karlsson, Karin
Ghia, Paolo
Janssens, Ann
Cymbalista, Florence
Woyach, Jennifer A
Salles, Gilles
Wierda, William G
Izumi, Raquel
Munugalavadla, Veerendra
Patel, Priti
Wang, Min Hui
Wong, Sofia
Byrd, John C
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_32305093
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32305093
Other Identifiers
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(20)30262-2
